Results 61 to 70 of about 345,154 (283)

wcray/R21-doppler: Cardiac_Doppler_Parser

open access: yes, 2022
First public release of Bossenbroek/Bartlett/Ray/Trask Doppler Echocardiography pre-parser.
Jamie Bossenbroek, wcray
core   +1 more source

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner   +10 more
wiley   +1 more source

'Color Doppler stripes’ make it difficult to diagnose the severity of valvular heart diseases: a report of two cases

open access: yesCardiovascular Ultrasound
Background Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the ‘color Doppler stripe’ can complicate diagnosis.
Yuichi Baba   +7 more
doaj   +1 more source

VALUE OF STRESS ECHOCARDIOGRAPHY IN DIAGNOSIS OF VIABLE MYOCARDIUM IN PATIENTS WITH ISCHEMIC HEART DISEASE

open access: yesРациональная фармакотерапия в кардиологии, 2016
The main methods of viable myocardium diagnosis in patients with ischemic heart disease are discussed. Сurrent opportunities of stress echocardiography and tissue Doppler echocardiography in viable myocardium detection are presented.
D. N. Perutskiy   +2 more
doaj   +1 more source

Clinical and Echocardiographic Findings of Left Ventricular Diastolic Dysfunction Among Hypertensive Patients at Muhimbili National Hospital, Dar es Salaam [PDF]

open access: yes, 2012
Hypertension is the commonest of the cardiovascular risk factors, whose prevalence in Tanzania is high between 20-30%, among rural and urban residents respectively.
Sanga, T.S, Sanga, Tulizo Shemu
core  

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy   +15 more
wiley   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li   +12 more
wiley   +1 more source

Evaluation of diagnostic power of tissue Doppler Echocardiography for Assessment of cardiac iron overload in patients with thalassemia major

open access: yesInternational Journal of Hematology-Oncology and Stem Cell Research, 2012
Background and Aim: Iron overload in patients with thalassemia major is one of the most important complications of this disease and its cardiac complications are the most important causes of death in these patients.MRI T2 is the perfect device to assess ...
Reza Alizadeh   +6 more
doaj  

Doppler echocardiography during pregnancy: Physiological and abnormal findings

open access: yes, 1996
Despite continuous improvements in diagnostic cardiology techniques, echocardiography remains the cornerstone for noninvasive cardiovascular assessment of the pregnant woman with heart disease or suspected cardiac abnormality.
ORLANDO CAMPOS   +1 more
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy